 |
 |
|
 |
|
Welcome to edition #1 of the SWOG Update.
For all members and friends of the Southwest Oncology Group, the SWOG Update will keep you informed of what's happening with the Group. News to report? Send it to communications@swog.org.
|
|
|
|
 |
| |
 |
|
 |
|
Why we do what we do
Our mission is straightforward: to make progress in the prevention and cure of cancer through clinical research. Our research objectives define how we work to accomplish our mission.
[more]
|
|
|
|
 |
 |
|
|
|
You, your colleagues, and your cooperative group in the media ...
|
|
|
|
|
|
 |
|
|
|
Funding opportunities, deadlines, and updates
Clock's ticking: Upcoming deadlines
- Aug. 14: SWOG Translational Medicine Development Fund
- Aug. 31: Coltman Fellowship
- Aug. 31: Coltman Translational Medicine Fellowship
- Sep. 1: Aventis Urologic Fellowship
Translational Science Award application deadline is August 14
SWOG's Translational Medicine Committee has launched the Translational Medicine Development Fund to support novel translational research that uses SWOG tissues or other resources.
The purpose of the Fund is to help harmonize the Group, cancer centers, and SPOREs, while fostering the development of creative trial capsules and protocols.
Awards will be made through a competitive, peer-review process. Individual projects may be funded for up to $175,000 per year for a period of one to three years.
Read the RFA to learn more (PDF).
NCI RFAs for funding
The NCI Early Detection Research Network has posted several Requests for Applications for funding:
NIH peer review scoring guidelines updated
This past spring the NIH announced a revised scoring procedure for evaluating research funding applications for FY2010. The new system uses a 1 – 9 scale (1 being "exceptional") rather than the old 1 – 5 system. Note that this new system is being applied to all applications for ARRA-related funding.
Learn more about the updated NIH peer review process.
|
|
|
|
 |
|
